Stramipla Injection 1 ml belongs to a group of medications called corticosteroids. It is primarily used to treat the pain of osteoarthritis (OA) in the knee and helps to reduce the joint pain, stiffness, and swelling associated with inflammatory disorders. Osteoarthritis is a common type of arthritis in which the cartilage that cushions the bone's ends erodes due to wear and tear over time. Common symptoms are joint pain and stiffness. The risk of osteoarthritis increases with increasing age.

Stramipla Injection 1 ml contains ‘triamcinolone’, which belongs to the class of corticosteroids. It works by blocking the production of certain chemical messengers in the body that cause inflammation (redness and swelling) and allergies. Thus, it helps reduce swelling, pain and discomfort.

Stramipla Injection 1 ml will be administered by a healthcare professional. Do not self-administer. Sometimes Stramipla Injection 1 ml may cause certain side effects such as sore throat, runny nose, sinusitis, dizziness, nervousness, cough, contusions (bleeding under the skin) and injection site reactions. Most of these side effects do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

Stramipla Injection 1 ml should be avoided if you are allergic to it. If you are pregnant or breastfeeding, inform your doctor before receiving this injection. It is not recommended for use in children below 12 years of age. Stramipla Injection 1 ml is intended for intra-articular use only. If you have osteoporosis (weak bones) or any other bone or joint relations problems, inform your doctor before receiving Stramipla Injection 1 ml. Stramipla Injection 1 ml may cause dizziness; hence it is advised to avoid driving vehicles or operating machines after receiving this injection.

Stramipla Injection 1 ml contains 'Triamcinolone,' a corticosteroid. It works by blocking the production of certain chemical messengers in the body that cause inflammation and allergies. Thus, it helps reduce osteoarthritis symptoms such as pain, inflammation, swelling and stiffness.

Please inform your doctor if you are allergic to it and if you are using any prescription, or non-prescription medicines, including vitamin and herbal supplements, before receiving Stramipla Injection 1 ml. This medicine weakens your immune system making you more prone to infections. So, keep a distance from people who are sick or have infections. Pregnant and breastfeeding women should consult their doctor before taking this medicine. Stramipla Injection 1 ml is not recommended for use in children 12 years of age as the safety and efficacy are not established. If you have osteoporosis (weak bones) or any other bone or joint relations problems or have a recent history of heart, liver or kidney diseases, glaucoma, cataracts, nasal surgery, and chronic nasal inflammation, insomnia, or mood swings, inform your doctor before receiving Stramipla Injection 1 ml. This medicine may cause dizziness; hence it is advised to avoid driving vehicles or operating machines after receiving this injection.

• Perform gentle activities like 20-30 minutes of walking or swimming. Physical activity helps strengthen muscles and relieves joint stiffness.
• Perform yoga as it may help in improving joint flexibility and pain management.
• Maintain a healthy weight by performing regular low-strain exercises and eating healthy food.
• Get adequate sleep, as resting the muscles can help reduce inflammation and swelling.
• De-stress yourself by meditating, reading books, taking a warm bubble bath or listening to soothing music.
• Acupuncture, massage, and physical therapy may also be helpful.
• Limit salt intake and prefer herbs or spices like garlic, ginger and turmeric, a natural anti-inflammatory.
• Try to avoid alcohol, as it can affect your stomach and intestine and limit the absorption of the essential nutrients required by your body.

Stramipla Injection 1 ml is intended for intra-articular use only. Hence do not administer this medicine by epidural, intrathecal, intravenous, intraocular, intramuscular, intradermal, or subcutaneous routes.